Australia markets open in 1 hour 58 minutes

Travere Therapeutics, Inc. (TVTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.72+0.83 (+10.52%)
At close: 04:00PM EDT
8.87 +0.15 (+1.72%)
After hours: 05:21PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-161,129
-111,399
-278,482
-180,091
-169,431
-
Depreciation & amortisation
41,790
38,530
20,719
12,746
24,579
-
Deferred income taxes
-
-
-
-
-
0
Stock-based compensation
40,533
44,246
38,143
29,566
23,614
-
Change in working capital
-7,342
-25,475
875
80,775
-26,042
-
Accounts receivable
-8,153
-11,264
-1,060
853
2,301
-
Inventory
-40,734
-39,420
-1,209
117
-5,067
-
Accounts payable
273
24,763
2,055
2,467
-6,036
-
Other working capital
-338,667
-322,280
-214,848
-38,943
-162,588
-
Other non-cash items
-7,746
-1,908
2,968
15,461
101,609
-
Net cash provided by operating activities
-317,909
-280,021
-186,291
-14,792
-42,743
-
Cash flows from investing activities
Investments in property, plant and equipment
-20,758
-42,259
-28,557
-24,151
-119,845
-
Acquisitions, net
-
-
-
-
-
0
Purchases of investments
-340,752
-443,942
-385,389
-547,076
-214,964
-
Sales/maturities of investments
351,821
334,575
381,993
433,604
273,482
-
Other investing activities
-
-
-600
-
-
-
Net cash used for investing activities
197,713
55,776
-32,553
-137,623
-61,327
-
Cash flows from financing activities
Debt repayment
-
0
-211,324
0
-
0
Common stock issued
-1
191,198
19,545
224,934
131,520
-
Other financing activities
-2,100
-2,100
-11,982
-2,100
-9,748
-
Net cash used provided by (used for) financing activities
2,009
220,134
120,052
237,787
127,713
-
Net change in cash
-118,125
-3,512
-104,065
80,981
22,336
-
Cash at beginning of period
161,376
61,688
165,753
84,772
62,436
-
Cash at end of period
42,411
58,176
61,688
165,753
84,772
-
Free cash flow
Operating cash flow
-317,909
-280,021
-186,291
-14,792
-42,743
-
Capital expenditure
-20,758
-42,259
-28,557
-24,151
-119,845
-
Free cash flow
-338,667
-322,280
-214,848
-38,943
-162,588
-